Printer Friendly

COMPANY INFORMATION
DiagnoCure Inc. 6e étage, 2050 boul René-Lévesque O Québec, QC G1V 2K8 Tel: (418) 527-6100 Toll-free: (888) 900-6626 Fax: (418) 527-0240 Contact Name Jean-François Bureau Industry Pharmaceuticals		Key Executives John C. Schafer, CEO Jean-François Bureau, CFO Develops molecular tests for the detection and management of cancer. Lead products are Previstage™ GCC (guanylyl cyclase C) colorectal cancer staging test and PCA3 prostate cancer test (by Gen-Probe Inc.).
FP ADVISOR COVERAGE DiagnoCure Inc. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Investor Reports • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/CUR $1.06 $1.40 $0.75 n.a. n.a. n.a. 1.5 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 46,104 n.a. $-0.30 Oct. 31/09 11.58% -37.44% -28.06% $45,535
ANNUAL FINANCIALS Periods ended: 12m Oct. 31/09 12m Oct. 31/08 12m Oct. 31/07 $000s $000s $000s Operating revenue 1,113 787 2,273 Net income (12,865) (13,834) (9,156) Total assets 26,350 33,146 43,585 $ $ $ Earnings per share* (0.30) (0.33) (0.24) % % % Return on equity (54.74) (39.62) (30.57)   * Common

COMPANY NEWS

Results for 'DiagnoCure Inc.' from past 30 days: No hits. (Links are to articles.)